Climb Bio, Inc.
CLYM
$7.02
-$0.10-1.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.13% | -44.89% | 84.21% | -1,124.57% | -131.15% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.25% | 32.18% | -99.06% | 173.36% | -3.93% |
| Change in Net Operating Assets | -24.22% | -112.18% | -252.07% | 714.22% | 17.66% |
| Cash from Operations | -183.19% | -60.68% | -1,571.36% | -748.49% | -483.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.82% | 121.41% | 197.26% | -410.89% | -245.34% |
| Cash from Investing | 147.82% | 121.26% | 149.62% | -410.89% | -245.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -77.66% | -- | -- | -- | 1.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 65.60% | -- | -- | -- | -- |
| Cash from Financing | -151.22% | -- | -- | -- | -85.76% |
| Foreign Exchange rate Adjustments | -- | -- | 26.32% | 14.29% | 82.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.76% | 104.06% | -105.37% | -588.37% | -264.84% |